KDR and cancer: Cancer cells are known for their ability to produce autocrine growth factors that contribute to their abnormal growth rate and 20-HETE in a dose-dependent manner induced endothelial cells (ECs) proliferation, increasing VEGF expression and its release activated by VEGF-VEGF-R2 pathway [20].